Skip to main content

Share story

Policy

FTC Releases Agenda for January 28 Workshop Examining Age Verification Technologies

The Federal Trade Commission released the agenda for its January 28, 2026, workshop examining age verification and estimation technologies. The workshop will explore technologies that assist companies in obtaining age information from visitors to websites and other online services. It will take place both online and in person. FTC Chairman Andrew N. Ferguson will deliver opening remarks. Commissioner Mark R. Meador and Bureau of Consumer Protection Director Christopher Mufarrige will also speak. Four panel discussions will address issues such as why age verification matters, types of age verification tools, navigating the regulatory maze around age verification, how to deploy age verification at scale, and the interplay between age verification technologies and the Children's Online Privacy Protection Act Rule. The workshop is free and open to the public. No registration is required. In-person sessions will be held at the Constitution Center at 400 7th St. SW, Washington, D.C. 20024. The event will be webcast at FTC.gov, with additional details available on the event page.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from FTC and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Nominal raises $240 million at a $3 billion valuation

Nominal has raised $240 million at a $3 billion valuation, triple its valuation in a funding round earlier this year, Bloomberg reports. The startup builds software to make manufacturing more efficient.

Capital Products
Capital Products

Onodrim raises $300M to acquire European defence and industrial suppliers

Amsterdam-based Onodrim Industries has raised $300M in a round led by Lux Capital, valuing the defence group at $1.3bn, the company said Monday. Other investors include General Catalyst, Lakestar and Altimeter. The financing follows its €40M seed round in February.

Capital
Capital

SRTD Biotech raises €31.5 million for targeted RNA therapies

SRTD Biotech has completed an oversubscribed €31.5 million seed financing to develop RNA therapies designed to act selectively inside diseased cells. Mérieux Equity Partners led the round, with NRW.BANK and Boehringer Ingelheim Venture Fund joining as co-leads.